Damodar Tissue Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 7.10 M
- Company Age 26 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 0.18%
- Profit Growth -32.35%
- Ebitda -49.54%
- Net Worth 12.10%
- Total Assets -5.07%
About Damodar Tissue
Damodar Tissue Private Limited (DTPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 05 November 1998 and has a history of 26 years and three months. Its registered office is in Aligarh, Uttar Pradesh, India.
The Corporate was formerly known as Pushpanjali Impex Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.10 M, as per Ministry of Corporate Affairs (MCA) records.
Himanshu Bhatia and Ridhima Trikha serve as directors at the Company.
Company Details
- Location
Aligarh, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21000UP1998PTC095906
- Company No.
095906
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Nov 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Damodar Tissue?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Bhatia  | Director | 28-Jun-2016 | Current |
| Ridhima Trikha | Director | 04-May-2022 | Current |
Financial Performance of Damodar Tissue.
Damodar Tissue Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.18% increase. The company also saw a substantial fall in profitability, with a 32.35% decrease in profit. The company's net worth Soared by an impressive increase of 12.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Damodar Tissue?
In 2023, Damodar Tissue had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vkd Agro Farm LlpHimanshu Bhatia is a mutual person
- Pawan Bhatia Wealth Management Llp
Himanshu Bhatia is a mutual person
- Krishnanchal Pulp & Papers Private Limited
Himanshu Bhatia is a mutual person
- Indo Global Papers Private Limited
Himanshu Bhatia is a mutual person
- Nandini Papers Private Limited
Himanshu Bhatia is a mutual person
- Nath Paper Private Limited
Himanshu Bhatia and Ridhima Trikha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Damodar Tissue?
Unlock and access historical data on people associated with Damodar Tissue, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Damodar Tissue, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Damodar Tissue's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
